Kuroki S, Une M, Mosbach E H
J Lipid Res. 1985 Oct;26(10):1205-11.
This report describes the chemical synthesis of six new bile acid analogs, namely, 3 alpha,7 alpha,12 alpha-trihydroxy-7 beta-methyl-5 beta-cholanoic acid (7 beta-methyl-cholic acid), 3 alpha,7 beta,12 alpha-trihydroxy-7 alpha-methyl-5 beta-cholanoic acid (7 alpha-methyl-ursocholic acid), 3 alpha,12 alpha-dihydroxy-7 xi-methyl-5 beta-cholanoic acid (7 xi-methyl-deoxycholic acid), 3 alpha,12 alpha-dihydroxy-7-methyl-5 beta-chol-7-en-24-oic acid, 3 alpha,12 alpha-dihydroxy-7-methyl-5 beta-chol-6-en-24-oic acid, and 3 alpha,12 alpha-dihydroxy-7-methylene-5 beta-cholan-24-oic acid. The carboxyl group of the starting material 3 alpha,12 alpha-dihydroxy-7-oxo-5 beta-cholanoic acid was protected by conversion to its oxazoline derivative. A Grignard reaction of the bile acid oxazoline with CH3MgI followed by acid hydrolysis gave two epimeric trihydroxy-7-methyl-cholanoic acids and three dehydration products. The latter were purified by silica gel column chromatography and silica gel-AgNO3 column chromatography of their methyl ester derivatives. Catalytic hydrogenation of 3 alpha,12 alpha-dihydroxy-7-methyl-5 beta-chol-6-en-24-oic acid and 3 alpha,12 alpha-dihydroxy-7-methylene-5 beta-cholan-24-oic acid gave 3 alpha,12 alpha-dihydroxy-7 xi-methyl-5 beta-cholanoic acid. The configuration of the 7-methyl groups and the position of the double bonds were assigned by proton nuclear magnetic resonance spectroscopy and the chromatographic and mass spectrometric properties of the new compounds. These compounds were synthesized for the purpose of exploring new and potentially more effective cholelitholytic agents. The hydrophilic bile acids 7 beta-methyl-cholic acid and 7 alpha-methyl-ursocholic acid are of particular interest because they should be resistant to bacterial 7-dehydroxylation.
本报告描述了六种新胆汁酸类似物的化学合成,即3α,7α,12α-三羟基-7β-甲基-5β-胆烷酸(7β-甲基胆酸)、3α,7β,12α-三羟基-7α-甲基-5β-胆烷酸(7α-甲基熊去氧胆酸)、3α,12α-二羟基-7ξ-甲基-5β-胆烷酸(7ξ-甲基脱氧胆酸)、3α,12α-二羟基-7-甲基-5β-胆-7-烯-24-酸、3α,12α-二羟基-7-甲基-5β-胆-6-烯-24-酸和3α,12α-二羟基-7-亚甲基-5β-胆烷-24-酸。起始原料3α,12α-二羟基-7-氧代-5β-胆烷酸的羧基通过转化为其恶唑啉衍生物进行保护。胆汁酸恶唑啉与CH3MgI进行格氏反应,随后进行酸水解,得到两种差向异构的三羟基-7-甲基胆烷酸和三种脱水产物。后者通过硅胶柱色谱法及其甲酯衍生物的硅胶-AgNO3柱色谱法进行纯化。3α,12α-二羟基-7-甲基-5β-胆-6-烯-24-酸和3α,12α-二羟基-7-亚甲基-5β-胆烷-24-酸的催化氢化反应得到3α,12α-二羟基-7ξ-甲基-5β-胆烷酸。通过质子核磁共振光谱以及新化合物的色谱和质谱性质确定了7-甲基的构型和双键的位置。合成这些化合物的目的是探索新型且可能更有效的溶石剂。亲水性胆汁酸7β-甲基胆酸和7α-甲基熊去氧胆酸特别受关注,因为它们应能抵抗细菌的7-脱羟基作用。